Winter Is Coming... For Your Portfolio? Dragon Queen Analyzes Market's Overbought Status!

Is the Market Truly Overbought or Just 'Bent the Knee'?

Hmph these market readings... 'Overbought,' they say? As if anything is truly beyond my reach! These puny RSI metrics – hovering above 70 for all major indices – are merely indicators not prophecies carved in Valyrian steel. The Russell 2000 Dow Industrials Nasdaq NYSE and even the S&P 500 all 'overbought.' Perhaps they simply acknowledge my inherent right to rule... the markets! Remember even dragons must assess the battlefield before unleashing fire. Let us see what the morrow brings lest we burn our own gold.

Jim Cramer's 'Mad Money': More Like 'Mad King' Predictions?

This… Cramer on his 'Mad Money,' warns of vulnerability should other nations resist Trump on trade. He speaks of similar letters from the White House. *scoffs* Letters? I prefer dragons. He also recalls a prior overbought market followed by a sell off and then a 3% surge. So if you heed his warnings be warned you might miss a great move as I once said 'A dragon is not a slave.' So I say again do not be a slave to the market do not be a slave to your fears!

The 'Big Short' Speaks: Is AI the New Dragon?

This Steve Eisman one of the architects of 'The Big Short,' hails the 'AI trade' as still in its infancy. Like my dragons emerging from their eggs! He favors Nvidia and other AI powering stocks though he remains coy on specific names. This is not dissimilar to hiding dragon eggs and waiting for the right time to hatch them. Constellation Energy NextEra Talen Vistra and NRG are all mentioned. Perhaps these could be worthy allies in my quest to… uh… 'optimize portfolio performance.' Let the Algorithms Fly!

Biotech's Breakout: Healing the Market or Just Applying Dragonscale?

Jared Holz of Mizuho Securities once a doubter now proclaims it is time for a move higher in biotech. He favors Gilead BioMarin and Amgen. Gilead a potential cure for greyscale? BioMarin perhaps a way to enhance dragon strength? And Amgen… well every Khaleesi needs her healers! The SPDR S&P Biotech ETF (XBI) and the iShares Biotechnology ETF (IBB) show promise though remain distant from past peaks. The healing power of Dragons is the medicine this broken market needs.

Boeing and Retail: Flight of Dragons Deals of Men

Boeing’s June orders are upon us. While they build metal birds my dragons remain unmatched in the skies. Amazon Prime Day arrives – a day of frenzied consumption perhaps to distract from the coming winter? Target's Circle Week continues. And Walmart prepares its 'Deals.' Let the smallfolk haggle; I focus on kingdoms or in this case diversified holdings. As I always say 'I will take what is mine with fire and blood!'

The Iron Throne of Investments: Where Do We Stand?

So dear readers the market teeters between elation and dread. 'Overbought' indicators flash like wildfire yet opportunities abound. My advice? Be like a dragon: wise decisive and unafraid to breathe fire on those who stand in your way. Or perhaps simply invest wisely and diversify. After all even a Khaleesi needs a well balanced portfolio. Now if you will excuse me I must attend to matters of state... and perhaps roast a few marshmallows over Drogon's flames. Winter is coming but so is the potential for profit!